Role of the high mobility group box 1 signalling axes via the receptor for advanced glycation end‐products and toll‐like receptor‐4 in the immunopathology of oral lichen planus: a potential drug target?

No abstract is available for this paper.

• Publication year

  2018

• Venue

  European Journal of Oral Sciences

• Publication date

  2018-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/eos.12416PMID 29676511
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cancer risk of Lichen planus: A cohort study of 13,100 women in Finland

  2018cited by this paper
• Histamine H4 receptor signalling in tongue cancer and its potential role in oral carcinogenesis - a short report

  2017cited by this paper
• Histamine metabolism and transport are deranged in human keratinocytes in oral lichen planus

  2017cited by this paper
• Altered Expression of Toll-like Receptors in Human Oral Epithelium in Oral Lichenoid Reactions

  2017cited by this paper
• Medical Management of Oral Lichen Planus: A Systematic Review.

  2016cited by this paper
• HMGB1 as biomarker and drug target.

  2016cited by this paper
• Clinical Value of High Mobility Group Box 1 and the Receptor for Advanced Glycation End-products in Head and Neck Cancer: A Systematic Review

  2016cited by this paper
• High Mobility Group Box Protein 1 (HMGB1): The Prototypical Endogenous Danger Molecule

  2015cited by this paper
• Epithelial Cell Apoptosis in Recurrent Aphthous Ulcers

  2015cited by this paper
• HMGB1 genetic polymorphisms in oral squamous cell carcinoma and oral lichen planus patients.

  2015cited by this paper
• Histamine H4 receptor in oral lichen planus.

  2015cited by this paper
• Oral lichen planus: focus on etiopathogenesis.

  2013cited by this paper
• Diagnostic Significance of Serum HMGB1 in Colorectal Carcinomas

  2012cited by this paper
• HMGB1 is a therapeutic target for sterile inflammation and infection.

  2011cited by this paper
• Pathophysiology, etiologic factors, and clinical management of oral lichen planus, part I: facts and controversies.

  2010cited by this paper
• HMGB1 and RAGE in inflammation and cancer.

  2010cited by this paper
• Correlation between clinical and histopathologic diagnoses of oral lichen planus based on modified WHO diagnostic criteria.

  2009cited by this paper
• Tumor necrosis factor-alpha stimulates gingival epithelial cells to release high mobility-group box 1.

  2007cited by this paper
• High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal

  2005cited by this paper
• The pathogenesis of oral lichen planus.

  2002cited by this paper
• Dual roles for HMGB1: DNA binding and cytokine

  2001cited by this paper

• The RAGE Pathway in Skin Pathology Development: A Comprehensive Review of Its Role and Therapeutic Potential

  2024cites this paper
• MICROBES AND TOLL-LIKE RECEPTORS IN ORAL LICHENOID DISEASE AND ORAL SQUAMOUS CELL CARCINOMA

  2020cites this paper
• Nothing to Sneeze at: Histamine and Histamine Receptors in Oral Carcinogenesis.

  2020cites this paper
• Associations of HMGB1 gene polymorphisms with risk of coal workers’ pneumoconiosis susceptibility in Chinese Han population

  2020cites this paper
• The Prognostic Value of Toll-Like Receptors in Head and Neck Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis

  2020cites this paper
• The receptor for advanced glycation end products is a sensor for cell‐free heme

  2020cites this paper
• HMGB1 aggravates lipopolysaccharide-induced acute lung injury through suppressing the activity and function of Tregs.

  2020cites this paper
• Human β-Defensin 2 Expression in Oral Epithelium: Potential Therapeutic Targets in Oral Lichen Planus

  2019cites this paper
• Lichen planus: altered AIM2 and NLRP1 expression in skin lesions and defective activation in peripheral blood mononuclear cells

  2018cites this paper